Stephen J. O’Connor

1.3k total citations
37 papers, 935 citations indexed

About

Stephen J. O’Connor is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Stephen J. O’Connor has authored 37 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Stephen J. O’Connor's work include Healthcare Policy and Management (4 papers), Patient Satisfaction in Healthcare (2 papers) and Antimicrobial Peptides and Activities (2 papers). Stephen J. O’Connor is often cited by papers focused on Healthcare Policy and Management (4 papers), Patient Satisfaction in Healthcare (2 papers) and Antimicrobial Peptides and Activities (2 papers). Stephen J. O’Connor collaborates with scholars based in United States, Ireland and United Kingdom. Stephen J. O’Connor's co-authors include Harry R. Allcock, Y Saunders, Johanna Lynch, Richard Jones, David G. Lidzey, Anthony M. Higgins, R. B. Fletcher, Ilaria Grizzi, Paul C. Jukes and Richard L. Thompson and has published in prestigious journals such as Nature Materials, Biomaterials and Macromolecules.

In The Last Decade

Stephen J. O’Connor

36 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen J. O’Connor United States 18 179 178 151 139 127 37 935
Mi‐Ra Kim South Korea 21 350 2.0× 254 1.4× 341 2.3× 168 1.2× 163 1.3× 116 1.6k
Mark Rudolph United States 16 173 1.0× 106 0.6× 59 0.4× 550 4.0× 132 1.0× 23 1.2k
Rong Zhou China 26 86 0.5× 354 2.0× 37 0.2× 73 0.5× 82 0.6× 138 1.9k
Zhoufeng Wang China 19 240 1.3× 354 2.0× 145 1.0× 105 0.8× 256 2.0× 71 1.6k
Meirong Liu China 22 488 2.7× 536 3.0× 227 1.5× 115 0.8× 79 0.6× 93 1.8k
Shinya Oku Japan 14 215 1.2× 166 0.9× 103 0.7× 59 0.4× 71 0.6× 31 886
Chen-Hsi Hsieh Taiwan 22 104 0.6× 297 1.7× 30 0.2× 50 0.4× 281 2.2× 112 1.6k
Charles R. Davis United States 20 104 0.6× 131 0.7× 73 0.5× 215 1.5× 27 0.2× 80 1.3k
Mariko Ando Japan 17 357 2.0× 135 0.8× 56 0.4× 88 0.6× 143 1.1× 44 1.3k

Countries citing papers authored by Stephen J. O’Connor

Since Specialization
Citations

This map shows the geographic impact of Stephen J. O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. O’Connor more than expected).

Fields of papers citing papers by Stephen J. O’Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. O’Connor. The network helps show where Stephen J. O’Connor may publish in the future.

Co-authorship network of co-authors of Stephen J. O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. O’Connor. A scholar is included among the top collaborators of Stephen J. O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. O’Connor. Stephen J. O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castro, Victoria, Ana J. Pérez-Berná, Sergey Kapishnikov, et al.. (2025). Rapid hepatitis C virus replication machinery removal after antiviral treatment with DAA monitored by multimodal imaging. Structure. 33(9). 1547–1564.e4.
2.
White, Christopher A., et al.. (2024). Demographic and training descriptive analysis of National and American Hockey League team physicians. Journal of Orthopaedics. 64. 73–80. 1 indexed citations
3.
Funaya, Charlotta, D. C. Rogers, Stephen J. O’Connor, et al.. (2023). Dehydration as alternative sample preparation for soft X‐ray tomography. Journal of Microscopy. 291(3). 248–255. 2 indexed citations
4.
Stark, Jeffrey G., et al.. (2023). Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis. Clinical Pharmacokinetics. 62(9). 1231–1241. 7 indexed citations
5.
White, Christopher A., et al.. (2022). Shoulder injuries in ice hockey players: Prevalence, common management, and return to play. Journal of Orthopaedics. 35. 145–149. 3 indexed citations
6.
Weech‐Maldonado, Robert, et al.. (2017). Hospitals’ use of hospitalists: Implications for financial performance. Health Care Management Review. 44(1). 10–18. 16 indexed citations
7.
O’Connor, Stephen J., et al.. (2017). The relationship between emergency department wait times and inpatient satisfaction. Health Marketing Quarterly. 34(2). 97–112. 20 indexed citations
8.
Weech‐Maldonado, Robert, et al.. (2016). Contextual factors associated with hospitals’ decision to operate freestanding emergency departments. Health Care Management Review. 42(3). 269–279. 21 indexed citations
9.
Devocelle, Marc, Shane T. Kenny, Maciej Guzik, et al.. (2015). The chain length of biologically produced (R)-3-hydroxyalkanoic acid affects biological activity and structure of anti-cancer peptides. Journal of Biotechnology. 204. 7–12. 16 indexed citations
10.
Ramamonjiarivelo, Zo, et al.. (2014). Public hospitals in financial distress. Health Care Management Review. 40(4). 337–347. 29 indexed citations
11.
O’Connor, Stephen J., Jasmina Nikodinović‐Runić, Aisling O’Connor, et al.. (2013). The anti-cancer activity of a cationic anti-microbial peptide derived from monomers of polyhydroxyalkanoate. Biomaterials. 34(11). 2710–2718. 51 indexed citations
12.
O’Connor, Stephen J.. (2011). Review of the incidence, prevalence, mortality and causative factors for lung cancer in Europe. European Journal of Cancer. 47. S346–S347. 11 indexed citations
13.
Lynch, Johanna, et al.. (2010). Screening for psychological distress in patients with lung cancer: results of a clinical audit evaluating the use of the patient Distress Thermometer. Supportive Care in Cancer. 19(2). 193–202. 80 indexed citations
14.
Constantinescu, Cristian C., Karmen K. Yoder, David A. Kareken, et al.. (2008). Estimation from PET data of transient changes in dopamine concentration induced by alcohol: support for a non-parametric signal estimation method. Physics in Medicine and Biology. 53(5). 1353–1367. 13 indexed citations
15.
DeCarr, Lynn B., Thomas M. Buckholz, Philip Coish, et al.. (2006). Identification of selective neuropeptide Y2 peptide agonists. Bioorganic & Medicinal Chemistry Letters. 17(2). 538–541. 16 indexed citations
16.
Smith, Roger A., Zahra Fathi, Su-Ellen Brown, et al.. (2006). Constrained analogs of CB-1 antagonists: 1,5,6,7-Tetrahydro-4H-pyrrolo[3,2-c]pyridine-4-one derivatives. Bioorganic & Medicinal Chemistry Letters. 17(3). 673–678. 18 indexed citations
17.
Chappell, John H., David G. Lidzey, Paul C. Jukes, et al.. (2003). Correlating structure with fluorescence emission in phase-separated conjugated-polymer blends. Nature Materials. 2(9). 616–621. 157 indexed citations
18.
19.
Gu, Wen‐Zhen, Sajeev Cherian, Stephen J. O’Connor, et al.. (1999). Effect of novel CAAX peptidomimetic farnesyltransferase inhibitor on angiogenesis in vitro and in vivo. European Journal of Cancer. 35(9). 1394–1401. 37 indexed citations
20.
O’Connor, Stephen J., et al.. (1992). Alaska/Magadan EMS project: phase two.. PubMed. 34(1). 28–37. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mi‐Ra Kim Breakdown of academic impact, for papers by Mark Rudolph Breakdown of academic impact, for papers by Rong Zhou Breakdown of academic impact, for papers by Zhoufeng Wang Breakdown of academic impact, for papers by Meirong Liu Breakdown of academic impact, for papers by Shinya Oku Breakdown of academic impact, for papers by Chen-Hsi Hsieh Breakdown of academic impact, for papers by Charles R. Davis Breakdown of academic impact, for papers by Mariko Ando
Rankless by CCL
2026